Privacy    
 
  Citi Research Disclosures


ABCDEFGHIJKLMNOPQRSTUVWXYZ#




Disclosures Home
Conflicts Management Policy
SEBI Investor Charter & Complaint Information
SEBI Prescribed Client Terms & Conditions
Staff Conflicts
Terms of Use

 
Valuation & Risks ( ACGL ) Disclosure / Price Chart(s) / Valuation & Risk
Fundamental Equity Research
Our target price of $113 implies multiples of 11X blended 2026/2027 EPS and 1.8X F12M book and represents a modest discount to our estimate of intrinsic value. We value the company by discounting capital-adjusted earnings assuming a cost of equity of 9% and terminal growth rate of ~3.5% (vs. the 10% and 4% implied by industry multiples over the past 20 years). The company has traded at 12-13X F12M EPS and 1.3-1.4X last reported book value versus industry averages of 11-12X and 1.3-1.4X, respectively, over the past 20 years.

Downside risks to our price target include: Economic weakness growth could hinder revenues through lower exposures and reinvestment rates; insurance rate decreases could hinder ST revenue growth and LT margins; reserve inadequacies could benefit margins; lower interest rates could pressure reinvestment rates and impact net investment income, while higher interest rates could adversely impact book value; higher inflation could adversely impact margins (current and prior years), while lower inflation could lead to lower reinvestment rates and adversely impact net investment income; catastrophes losses could create downside to earnings and capital, while lack of catastrophe losses could benefit pricing; and technological/societal change could adversely impact operations, demand, expenses, and competitive position.

 

 

citiPrivacy
www.citigroup.com Terms, conditions, caveats, and small print
Copyright © 2025 Citi